Works matching IS 00316970 AND DT 2019 AND VI 75 AND IP 3

Results: 17

Do clinical and laboratory parameters predict thiopurine metabolism and clinical outcome in patients with inflammatory bowel diseases?

Published in:

European Journal of Clinical Pharmacology, 2019, v. 75, n. 3, p. 335, doi. 10.1007/s00228-018-02616-7

By:

Frick, Sven;
Müller, Daniel;
Kullak-Ublick, Gerd A.;
Jetter, Alexander

Publication type:

Article

Efficacy of vitamin C for the prevention and treatment of upper respiratory tract infection. A meta-analysis in children.

Published in:

European Journal of Clinical Pharmacology, 2019, v. 75, n. 3, p. 303, doi. 10.1007/s00228-018-2601-7

By:

Vorilhon, Philippe;
Arpajou, Bastien;
Vaillant Roussel, Hélène;
Merlin, Étienne;
Pereira, Bruno;
Cabaillot, Aurélie

Publication type:

Article

Population pharmacokinetics of oxcarbazepine active metabolite in Chinese paediatric epilepsy patients and its application in individualised dosage regimens.

Published in:

European Journal of Clinical Pharmacology, 2019, v. 75, n. 3, p. 381, doi. 10.1007/s00228-018-2600-8

By:

Lin, Wei-wei;
Li, Xi-wen;
Jiao, Zheng;
Zhang, Jin;
Rao, Xin;
Zeng, Da-yong;
Lin, Xin-hua;
Wang, Chang-lian

Publication type:

Article

Pharmacokinetics of free and total mycophenolic acid in adult lupus nephritis patients—implications for therapeutic drug monitoring.

Published in:

European Journal of Clinical Pharmacology, 2019, v. 75, n. 3, p. 371, doi. 10.1007/s00228-018-2599-x

By:

Łuszczyńska, Paulina;
Pawiński, Tomasz;
Kunicki, Paweł K.;
Durlik, Magdalena;
Augustyniak-Bartosik, Hanna;
Hurkacz, Magdalena

Publication type:

Article

Deprescribing in multi-morbid older people with polypharmacy: agreement between STOPPFrail explicit criteria and gold standard deprescribing using 100 standardized clinical cases.

Published in:

European Journal of Clinical Pharmacology, 2019, v. 75, n. 3, p. 427, doi. 10.1007/s00228-018-2598-y

By:

Curtin, Denis;
Dukelow, Tim;
James, Kirstyn;
O'Donnell, Desmond;
O'Mahony, Denis;
Gallagher, Paul

Publication type:

Article

Applying DoTS adverse drug reactions classification to reports from hospital stimulated reporting.

Published in:

European Journal of Clinical Pharmacology, 2019, v. 75, n. 3, p. 433, doi. 10.1007/s00228-018-2596-0

By:

Farcas, Andreea;
Bulik, Noemi Beatrix;
Popa, Andreea;
Mensah Achampong, Agatha;
Bucsa, Camelia;
Mogosan, Cristina

Publication type:

Article

Effect of N-acetyl cysteine (NAC) supplementation on positive and negative syndrome scale in schizophrenia: a systematic review and meta-analysis of randomised controlled trials.

Published in:

European Journal of Clinical Pharmacology, 2019, v. 75, n. 3, p. 289, doi. 10.1007/s00228-018-2595-1

By:

Ghaderi, Amir;
Bussu, Anna;
Tsang, Catherine;
Jafarnejad, Sadegh

Publication type:

Article

The impact of R353Q genetic polymorphism in coagulation factor VII on the initial anticoagulant effect exerted by warfarin.

Published in:

European Journal of Clinical Pharmacology, 2019, v. 75, n. 3, p. 343, doi. 10.1007/s00228-018-2594-2

By:

Shaul, Chanan;
Blotnick, Simcha;
Deutsch, Liat;
Rosenberg, Gilad;
Caraco, Yoseph

Publication type:

Article

Duration of new antidepressant use and factors associated with discontinuation among community-dwelling persons with Alzheimer's disease.

Published in:

European Journal of Clinical Pharmacology, 2019, v. 75, n. 3, p. 417, doi. 10.1007/s00228-018-2591-5

By:

Kettunen, Reetta;
Taipale, Heidi;
Tolppanen, Anna-Maija;
Tanskanen, Antti;
Tiihonen, Jari;
Hartikainen, Sirpa;
Koponen, Marjaana

Publication type:

Article

Efficacy and safety of BRAF inhibitors and anti-CTLA4 antibody in melanoma patients—real-world data.

Published in:

European Journal of Clinical Pharmacology, 2019, v. 75, n. 3, p. 329, doi. 10.1007/s00228-018-2590-6

By:

Polkowska, Marta;
Ekk-Cierniakowski, Paweł;
Czepielewska, Edyta;
Kozłowska-Wojciechowska, Małgorzata

Publication type:

Article

Statin-associated immune-mediated necrotizing myopathy: a retrospective analysis of individual case safety reports from VigiBase.

Published in:

European Journal of Clinical Pharmacology, 2019, v. 75, n. 3, p. 409, doi. 10.1007/s00228-018-2589-z

By:

Essers, Dirk;
Schäublin, Martina;
Kullak-Ublick, Gerd A.;
Weiler, Stefan

Publication type:

Article

A population-based study of transdermal fentanyl initiation in Australian clinical practice.

Published in:

European Journal of Clinical Pharmacology, 2019, v. 75, n. 3, p. 401, doi. 10.1007/s00228-018-2588-0

By:

Gisev, Natasa;
Pearson, Sallie-Anne;
Larance, Briony;
Larney, Sarah;
Blanch, Bianca;
Degenhardt, Louisa

Publication type:

Article

Selective serotonin re-uptake inhibitors and the risk of violent suicide: a nationwide postmortem study.

Published in:

European Journal of Clinical Pharmacology, 2019, v. 75, n. 3, p. 393, doi. 10.1007/s00228-018-2586-2

By:

Forsman, Jonas;
Masterman, Thomas;
Ahlner, Johan;
Isacsson, Göran;
Hedström, Anna Karin

Publication type:

Article

Prediction of mizoribine pharmacokinetic parameters by serum creatinine in renal transplant recipients.

Published in:

European Journal of Clinical Pharmacology, 2019, v. 75, n. 3, p. 363, doi. 10.1007/s00228-018-2584-4

By:

Chen, Pan;
Xu, Xuan;
Liu, Longshan;
Wu, Jingjing;
Li, Jingjie;
Fu, Qian;
Chen, Jie;
Wang, Changxi

Publication type:

Article

Association between activated partial thromboplastin time, age and bleeding events in NVAF patients receiving dabigatran.

Published in:

European Journal of Clinical Pharmacology, 2019, v. 75, n. 3, p. 321, doi. 10.1007/s00228-018-2583-5

By:

Ji, Qiuyi;
Xu, Qing;
Wang, Zi;
Li, Xiaoye;
Lv, Qianzhou

Publication type:

Article

Non randomized study on the potential of nitisinone to inhibit cytochrome P450 2C9, 2D6, 2E1 and the organic anion transporters OAT1 and OAT3 in healthy volunteers.

Published in:

European Journal of Clinical Pharmacology, 2019, v. 75, n. 3, p. 313, doi. 10.1007/s00228-018-2581-7

By:

Huledal, Gunilla;
Olsson, Birgitta;
Önnestam, Kristin;
Dalén, Per;
Lindqvist, Daniel;
Kruse, Matthias;
Bröijersén, Anders

Publication type:

Article

Effects of magnesium oxide on pharmacokinetics of L-dopa/carbidopa and assessment of pharmacodynamic changes by a model-based simulation.

Published in:

European Journal of Clinical Pharmacology, 2019, v. 75, n. 3, p. 351, doi. 10.1007/s00228-018-2568-4

By:

Kashihara, Yushi;
Terao, Yui;
Yoda, Kensaku;
Hirota, Takeshi;
Kubota, Toshio;
Kimura, Miyuki;
Matsuki, Shunji;
Hirakawa, Masaaki;
Irie, Shin;
Ieiri, Ichiro

Publication type:

Article